Published in J Hepatol on May 01, 1999
Endothelial-directed hepatic regeneration after partial hepatectomy. Ann Surg (2003) 1.34
Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol (1999) 1.13
Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease. Am J Pathol (2004) 0.90
Vascular endothelial growth factor and angiopoietins regulate sinusoidal regeneration and remodeling after partial hepatectomy in rats. World J Gastroenterol (2005) 0.89
Roles of vascular endothelial growth factor and endothelial nitric oxide synthase during revascularization and regeneration after partial hepatectomy in a rat model. Surg Today (2011) 0.86
Endothelium as master regulator of organ development and growth. Vascul Pharmacol (2008) 0.86
Liver sinusoidal endothelial cell modulation upon resection and shear stress in vitro. Comp Hepatol (2004) 0.84
Insulin promotes sinusoidal endothelial cell proliferation mediated by upregulation of vascular endothelial growth factor in regenerating rat liver after partial hepatectomy. World J Gastroenterol (2005) 0.81
Inhibition of VEGF- and NO-dependent angiogenesis does not impair liver regeneration. Am J Physiol Regul Integr Comp Physiol (2010) 0.81
Protective effects of ACLF sera on metabolic functions and proliferation of hepatocytes co-cultured with bone marrow MSCs in vitro. World J Gastroenterol (2011) 0.79
Preoperative administration of bevacizumab is safe for patients with colorectal liver metastases. World J Gastroenterol (2013) 0.79
Serial changes of serum growth factor levels and liver regeneration after partial hepatectomy in healthy humans. Int J Mol Sci (2013) 0.79
Advances in therapeutics for liver metastasis from colorectal cancer. World J Gastrointest Oncol (2010) 0.77
Prevention of liver fibrosis by intrasplenic injection of high-density cultured bone marrow cells in a rat chronic liver injury model. PLoS One (2014) 0.77
A Src family kinase inhibitor improves survival in experimental acute liver failure associated with elevated cerebral and circulating vascular endothelial growth factor levels. Liver Int (2011) 0.77
Age-related loss of responsiveness to 2,5-dimethoxy-4-iodoamphetamine in liver sinusoidal endothelial cells. J Gerontol A Biol Sci Med Sci (2013) 0.77
The vascular endothelial growth factor (VEGF) receptor-2 is a major regulator of VEGF-mediated salvage effect in murine acute hepatic failure. J Angiogenes Res (2010) 0.75
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell (1998) 10.32
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem (1996) 3.57
Structural characterization and biological functions of fibroblast growth factor. Endocr Rev (1987) 3.40
Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth. Nature (1987) 3.27
The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem (1992) 2.85
Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol (2009) 2.67
Hepatocyte proliferation in vitro: its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc Natl Acad Sci U S A (1984) 2.64
The need for liver transplantation: a nationwide estimate based on consensus review. Lancet (1995) 2.58
The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells. J Biol Chem (1985) 2.27
Fibroblast growth factor. Mol Cell Endocrinol (1986) 2.26
Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]. J Biol Chem (2000) 2.25
Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem (1988) 2.16
The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet (1983) 2.15
Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem (1996) 2.12
VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix. J Biol Chem (1997) 2.12
A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene (1995) 2.07
Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest (1993) 2.07
Characterization of the receptors for vascular endothelial growth factor. J Biol Chem (1990) 2.06
Basic and acidic fibroblast growth factors interact with the same cell surface receptors. J Biol Chem (1986) 2.01
Anorectal malformations and Down syndrome. Am J Med Genet (1989) 1.97
Molecular and biological characterization of fibroblast growth factor, an angiogenic factor which also controls the proliferation and differentiation of mesoderm and neuroectoderm derived cells. Cell Differ (1986) 1.75
Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. J Immunol (1995) 1.67
Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem (1998) 1.64
Molecular basis for the heterogeneity of human tyrosinase. Tohoku J Exp Med (1988) 1.58
Fibroblast growth factor: structural and biological properties. J Cell Physiol Suppl (1987) 1.52
Recurrent tetraamelia and pulmonary hypoplasia with multiple malformations in sibs. Am J Med Genet (1991) 1.52
Vascular endothelial growth factor and its receptors. Prog Growth Factor Res (1994) 1.50
Improvement in abduction of the shoulder after reconstructive soft-tissue procedures in obstetric brachial plexus palsy. J Bone Joint Surg Br (2007) 1.50
VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. J Biol Chem (1995) 1.47
Nitric oxide inhalation for paraquat-induced lung injury. J Toxicol Clin Toxicol (1998) 1.45
Computerised analysis of liver texture with correlation to needle biopsy. Ultraschall Med (2005) 1.43
Surgical correction of the medial rotation contracture in obstetric brachial plexus palsy. J Bone Joint Surg Br (2007) 1.42
Outcomes among tuberculosis patients with isoniazid resistance in Georgia, 2007-2009. Int J Tuberc Lung Dis (2012) 1.40
Successful use of recombinant activated factor VII (Novoseven) in controlling severe intra-abdominal bleeding after liver needle biopsy. Thromb Haemost (2002) 1.40
Fulminant non--A-G viral hepatitis leading to liver transplantation. Arch Intern Med (2000) 1.39
Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors. Biochem Biophys Res Commun (1993) 1.38
A practical guide to Papanicolaou smear rescreens: how many slides must be reevaluated to make a statistically valid assessment of screening performance? Cancer (1998) 1.38
Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. Proc Natl Acad Sci U S A (1987) 1.38
Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech Dev (2001) 1.38
Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population. Am J Hum Genet (1992) 1.32
Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J Biol Chem (1999) 1.28
Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology (1991) 1.23
Consanguinity in a population sample of Israeli Muslim Arabs, Christian Arabs and Druze. Ann Hum Biol (2002) 1.23
Arginine for glycine substitution in the triple-helical domain of the products of one alpha 2(I) collagen allele (COL1A2) produces the osteogenesis imperfecta type IV phenotype. J Biol Chem (1988) 1.22
Treatment outcome of multi-drug resistant tuberculosis in the United Kingdom: retrospective-prospective cohort study from 2004 to 2007. Euro Surveill (2013) 1.21
The identification of monoclonal class switch variants by sib selection and an ELISA assay. J Immunol Methods (1984) 1.21
Basic fibroblast growth factor: expression in cultured bovine vascular smooth muscle cells. Eur J Cell Biol (1988) 1.20
Pericentric inversions of chromosome 9 in two families. Cytogenetics (1972) 1.19
Low paternal dietary folate alters the mouse sperm epigenome and is associated with negative pregnancy outcomes. Nat Commun (2013) 1.18
Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J Biol Chem (1995) 1.18
Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells. J Biol Chem (1996) 1.18
The murine flg gene encodes a receptor for fibroblast growth factor. Oncogene (1990) 1.17
Sib risk of neural tube defect: is prenatal diagnosis indicated in pregnancies following the birth of a hydrocephalic child? J Med Genet (1979) 1.16
Genetic markers in migrants to Israel. Isr J Med Sci (1971) 1.15
Effect of dexmedetomidine on propofol requirements in healthy subjects. J Pharm Sci (2001) 1.14
Osteomyelitis in fractured sternum after cardiopulmonary resuscitation. N Engl J Med (1979) 1.14
Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice. Infect Immun (1998) 1.14
Influence of cardiac output on dexmedetomidine pharmacokinetics. J Pharm Sci (2000) 1.13
Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting. Epidemiol Infect (2010) 1.13
Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension. World J Gastroenterol (1999) 1.13
Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list'. Int J Tuberc Lung Dis (2013) 1.12
The ATC (ataxia-telangiectasia complementation group C) locus localizes to 11q22-q23. Genomics (1991) 1.11
Evolution of a genetic disease in an ethnic isolate: beta-thalassemia in the Jews of Kurdistan. Proc Natl Acad Sci U S A (1991) 1.11
A study of seroprevalence of HIV-1 and HIV-2 in six provinces of People's Republic of Angola: clues to the spread of HIV infection. J Acquir Immune Defic Syndr (1990) 1.10
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev (1996) 1.10
Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling. Cell Tissue Res (2006) 1.10
Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. J Biol Chem (1994) 1.10
Vascular endothelial growth factor receptor-1 and neuropilin-2 form complexes. J Biol Chem (2001) 1.09
Histocompatibility determinants in Israeli Jewish patients with coeliac disease: population and family study. Tissue Antigens (1981) 1.08
Volume of procedures at transplantation centers and mortality after liver transplantation. N Engl J Med (2000) 1.08
HLA-DRw4 in pemphigus vulgaris patients in Israel. Tissue Antigens (1980) 1.08
Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro. Infect Immun (1997) 1.08
Basic fibroblast growth factor is synthesized in cultured retinal pigment epithelial cells. Biochem Biophys Res Commun (1987) 1.07
Pituitary follicular cells produce basic fibroblast growth factor. Proc Natl Acad Sci U S A (1987) 1.06
Four sibs with arterial tortuosity: description and review of the literature. Am J Med Genet (1996) 1.06
Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. Blood (1993) 1.06
Vascular endothelial growth factor and angiopoietin in liver regeneration. Biochem Biophys Res Commun (2001) 1.05
PCR-based identification of new receptors: molecular cloning of a receptor for fibroblast growth factors. Oncogene (1991) 1.05
Idiopathic hypoparathyroidism in Israel. Isr J Med Sci (1981) 1.05
Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. J Biol Chem (1993) 1.05
Amelogenesis imperfecta among Israeli Jews and the description of a new type of local hypoplastic autosomal recessive amelogenesis imperfecta. Oral Surg Oral Med Oral Pathol (1979) 1.05
Association arrays for comparing familial total cholesterol, high density lipoprotein cholesterol, and triglyceride similarity in the Israeli population by country of origin. Am J Epidemiol (1982) 1.04
Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants. Proc Natl Acad Sci U S A (1985) 1.02
Gonadotrophin-induced gene regulation in human granulosa cells obtained from IVF patients. Modulation of steroidogenic genes, cytoskeletal genes and genes coding for apoptotic signalling and protein kinases. Mol Hum Reprod (2004) 1.02
A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. Int J Tuberc Lung Dis (2011) 1.02